Cronos Group Inc.CRON

時価総額

$11.7億

PER

グローバルなカンナビノイド製品・研究開発事業の有力企業。Spinach、PEACE NATURALS、Lord Jonesなどのブランドと微生物由来製品開発を展開。アルトリアが約40.9%を出資、2024年7月に子会社の支配権取得で買収。カナダ、米国、イスラエルを中心に展開。

	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	1,078	887	765	669	859
Short-term investments	212	118	113	192	-
Accounts receivable, net	9	22	23	14	15
Interest receivable	-	-	-	10	9
Other receivables	10	6	6	6	5
Current portion of loans receivable, net	7	5	9	6	1
Inventory, net	44	33	38	30	33
Prepaids and other current assets	11	9	7	5	6
Held-for-sale assets	1	-	-	-	8
Total current assets	1,372	1,080	960	933	936
Equity Method Investments	19	17	19	19	-
Other investments	-	118	71	35	3
Non-current portion of loans receivable, net	87	81	72	69	16
Property, plant and equipment, net	188	74	61	59	133
Right-of-use assets	10	9	2	1	1
Goodwill	180	1	1	1	63
Intangible assets, net	70	18	27	21	11
Deferred tax assets	-	-	-	-	3
Total assets	1,926	1,398	1,213	1,140	1,166
Accounts payable	-	11	11	12	17
Income taxes payable	-	-	33	0	0
Accrued liabilities	-	26	22	28	32
Current portion of lease obligation	1	3	1	1	1
Derivative liabilities	163	14	0	0	0
Other Liabilities, Current	-	-	-	0	-
Total current liabilities	207	54	68	41	50
Other Liabilities, Noncurrent	-	-	-	1	1
Operating Lease, Liability, Noncurrent	8	7	3	2	1
Deferred tax liabilities	-	0	-	-	4
Total liabilities	218	63	72	44	55
Common Stock, Value, Issued	569	595	611	614	670
Retained earnings	1,065	659	491	417	458
Accumulated other comprehensive income (loss)	43	50	-1	21	-64
Total equity attributable to shareholders of Cronos Group	1,711	1,337	1,144	1,100	1,111
Non-controlling interests	-3	-3	-3	-3	47
Total shareholders’ equity	1,708	1,334	1,141	1,096	1,111
Total liabilities and shareholders’ equity	1,926	1,398	1,213	1,140	1,166